Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer

Background/Aim: In the CheckMate-141 trial regarding head and neck cancer (HNC), nivolumab conferred a survival benefit to patients. However, the best treatment sequence of chemotherapy and anti-PD-1/PD-L1 therapy in these cancers is unclear. Patients and Methods: This was an observational study usi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:In Vivo
Autori principali: SATO, YASUYOSHI, FUKUDA, NAOKI, FUJIWARA, YU, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, NAKANO, KENJI, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Natura: Artigo
Lingua:Inglês
Pubblicazione: International Institute of Anticancer Research 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045096/
https://ncbi.nlm.nih.gov/pubmed/33622923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12371
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi